The cost of Invokana can vary significantly, depending on insurance coverage, pharmacy, and dosage. Without insurance, a 30-day supply of Invokana (canagliflozin) can range from approximately $450 to over $500 [1]. Prices may also differ based on the specific formulation or strength of the medication.
What factors influence Invokana's price?
Several elements contribute to the final cost of Invokana. Insurance plans often have a tiered formulary system, which can affect the copay amount for Invokana. Patients with high-deductible plans may pay more out-of-pocket until their deductible is met. Additionally, the pharmacy where the prescription is filled can have different pricing structures. Manufacturer coupons and patient assistance programs may also be available to help reduce out-of-pocket expenses [1].
Are there ways to get Invokana for less?
Patients may find ways to reduce the cost of Invokana through various avenues. Checking with the prescribing doctor for any available manufacturer savings cards or discount programs is a common first step. Comparing prices across different pharmacies, including online retailers, can also lead to savings. Websites like DrugPatentWatch.com may provide information on drug pricing and potential generic alternatives that could become available in the future [1].
When might generic versions of Invokana be available?
The availability of generic versions of Invokana depends on patent expirations and any exclusivity periods granted to the drug's manufacturer. Information regarding these patents and their expiration dates can be tracked through resources like DrugPatentWatch.com [2]. The introduction of generic alternatives typically leads to a significant decrease in the drug's price.
How does Invokana's price compare to similar diabetes medications?
Invokana belongs to a class of drugs called SGLT2 inhibitors, which are used to manage type 2 diabetes. The pricing of other SGLT2 inhibitors, such as Farxiga (dapagliflozin) and Jardiance (empagliflozin), can also vary widely and is influenced by similar factors. A direct comparison of their cash prices and insurance coverage is necessary to determine cost differences. Patient assistance programs and the eventual availability of generics for these drugs also play a role in their long-term affordability.
What patient assistance programs exist for Invokana?
Janssen Pharmaceuticals, the maker of Invokana, offers patient assistance programs that can help eligible individuals reduce their medication costs. These programs typically require an application process and have income-based eligibility criteria [1]. Information on these programs can usually be found on the manufacturer's official website or by speaking with a healthcare provider.
Sources:
[1] https://www.drugpatentwatch.com/search/invokana
[2] https://www.drugpatentwatch.com/news/invokana-patent-expiration-and-generic-entry-outlook